今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

NCT新成员来袭！NCT WISH 2月闪耀出道，开启爱豆新篇章

北京 – 2024年1月18日，SM娱乐公司正式宣布，NCT旗下最后一个分队将于2月正式出道，分队名为NCT WISH。该消息一出，立刻引发了全球粉丝的热烈关注。

NCT是SM娱乐公司推出的大型男子组合，以“无限扩张”为理念，拥有无限成员、无限分队、无限音乐风格等特点。自2016年出道以来，NCT凭借其独特的概念和多元化的音乐风格，迅速席卷全球，成为当今最具人气的男子组合之一。

NCT WISH作为NCT的最后一个分队，其出道备受瞩目。据悉，该分队由多名实力强劲的新成员组成，他们将在音乐、舞蹈等方面展现出与众不同的魅力。

目前，NCT WISH尚未公布具体成员名单和出道曲，但SM娱乐公司表示，将会在近期陆续公开相关信息。相信NCT WISH的出道，将为NCT注入新的活力，为粉丝们带来更加精彩的音乐舞台。

NCT WISH成员阵容备受期待

NCT WISH的成员名单尚未公布，但从SM娱乐公司以往推出的男团来看，NCT WISH的成员们应该都拥有着出色的唱跳实力和舞台表现力。此外，NCT WISH的成员们也可能来自不同的国家和地区，拥有不同的文化背景和语言能力，这将为NCT WISH的音乐作品增添更多的国际化元素。

NCT WISH出道曲将成焦点

NCT WISH的出道曲将是他们向世界展现实力的重要作品。这首歌曲将由NCT的御用制作人团队倾力打造，融合多种音乐风格，展现NCT WISH独有的音乐魅力。相信这首歌曲一定会成为NCT的又一首代表作，并获得粉丝们的热烈喜爱。

NCT WISH的未来发展

NCT WISH的出道，标志着NCT的“无限扩张”概念又迈进了一步。未来，NCT WISH将与NCT的其他分队一起，活跃在世界各地的音乐舞台上，为粉丝们带来更多精彩的音乐作品和舞台表演。

关于NCT

NCT是SM娱乐公司推出的大型男子组合，以“无限扩张”为理念，拥有无限成员、无限分队、无限音乐风格等特点。NCT目前共有四个分队：NCT U、NCT 127、NCT Dream和WayV。NCT的音乐风格多元化，融合了流行、嘻哈、R&B、电子等多种元素，深受世界各地粉丝的喜爱。

关于NCT WISH

NCT WISH是NCT的最后一个分队，将于2024年2月正式出道。该分队由多名实力强劲的新成员组成，将在音乐、舞蹈等方面展现出与众不同的魅力。NCT WISH的出道，将为NCT注入新的活力，为粉丝们带来更加精彩的音乐舞台。